Intra-Cellular Therapies Cash from Operations (TTM) Analysis

Intra-Cellular Therapies Inc (ITCI)

73.26 +1.13 (+1.57%) USD | NASDAQ | Apr 26, 16:00

73.33 +0.07 (+0.10%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-124.20M
September 30, 2023	-161.33M
June 30, 2023	-189.41M
March 31, 2023	-247.40M
December 31, 2022	-270.19M
September 30, 2022	-304.18M
June 30, 2022	-330.09M
March 31, 2022	-294.63M
December 31, 2021	-259.54M
September 30, 2021	-254.60M
June 30, 2021	-238.92M
March 31, 2021	-226.61M
December 31, 2020	-230.07M
September 30, 2020	-196.89M
June 30, 2020	-163.30M
March 31, 2020	-143.58M
December 31, 2019	-127.98M
September 30, 2019	-122.09M
June 30, 2019	-120.51M

Date	Value
March 31, 2019	-126.81M
December 31, 2018	-118.17M
September 30, 2018	-113.80M
June 30, 2018	-99.80M
March 31, 2018	-91.08M
December 31, 2017	-80.49M
September 30, 2017	-84.15M
June 30, 2017	-99.39M
March 31, 2017	-88.01M
December 31, 2016	-91.26M
September 30, 2016	-97.86M
June 30, 2016	-88.72M
March 31, 2016	-106.22M
December 31, 2015	-102.28M
September 30, 2015	-73.43M
June 30, 2015	-57.34M
March 31, 2015	-31.53M
December 31, 2014	-22.81M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-330.09M

Minimum

Jun 2022

-120.51M

Maximum

Jun 2019

-210.82M

Average

-226.61M

Median

Mar 2021

Cash from Operations (TTM) Benchmarks